COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

(2021) Anja Strangfeld et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia

(2020) Philippe Guilpain et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’

(2020) Kristin M D’Silva et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

(2020) Ennio Giulio Favalli et al.   JOURNAL OF RHEUMATOLOGY

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

(2020) Kelvin Kai-Wang To et al.   LANCET INFECTIOUS DISEASES

Virological assessment of hospitalized patients with COVID-2019

(2020) Roman Wölfel et al.   NATURE

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

(2020) Rebecca Haberman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B‐cells due to treatment with rituximab

(2020) Benedict Fallet et al.   Arthritis & Rheumatology

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

(2020) Robert BM Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al

(2020) Maurizio Benucci et al.   ANNALS OF THE RHEUMATIC DISEASES

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

(2020) Phil‐Robin Tepasse et al.   BRITISH JOURNAL OF HAEMATOLOGY

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

(2020) Divij Mathew et al.   SCIENCE

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab

(2020) Jan Leipe et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma

(2020) Hajime Yasuda et al.   Clinical Lymphoma Myeloma & Leukemia

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

(2020) Igor Kos et al.   Frontiers in Oncology

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

How to handle mortality when investigating length of hospital stay and time to clinical stability

(2011) Guy N Brock et al.   BMC Medical Research Methodology

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

(2010) Peter C. Austin   PHARMACEUTICAL STATISTICS

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE

Estimating and using propensity score in presence of missing background data: an application to assess the impact of childbearing on wellbeing

(2008) Alessandra Mattei   Statistical Methods and Applications